408 related articles for article (PubMed ID: 15019567)
1. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
[TBL] [Abstract][Full Text] [Related]
2. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
4. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic compound PHID (8-Phenyl-6a, 7, 8, 9, 9a, 10-hexahydro-6H-isoindolo [5, 6-g] quinoxaline-7, 9-dione) protects SH-SY5Y cells against MPP(+)-induced cytotoxicity through inhibition of reactive oxygen species generation and JNK signaling.
Kim IS; Koppula S; Kim BW; Song MD; Jung JY; Lee G; Lee HS; Choi DK
Eur J Pharmacol; 2011 Jan; 650(1):48-57. PubMed ID: 20946892
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347.
Lund S; Porzgen P; Mortensen AL; Hasseldam H; Bozyczko-Coyne D; Morath S; Hartung T; Bianchi M; Ghezzi P; Bsibsi M; Dijkstra S; Leist M
J Neurochem; 2005 Mar; 92(6):1439-51. PubMed ID: 15748162
[TBL] [Abstract][Full Text] [Related]
7. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
8. Role of extracellular-regulated kinase and c-Jun NH2-terminal kinase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurofilament phosphorylation.
De Girolamo LA; Billett EE
J Neurosci Res; 2006 Mar; 83(4):680-93. PubMed ID: 16447269
[TBL] [Abstract][Full Text] [Related]
9. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.
Silva RM; Kuan CY; Rakic P; Burke RE
Mov Disord; 2005 Jun; 20(6):653-64. PubMed ID: 15719422
[TBL] [Abstract][Full Text] [Related]
10. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice.
Ciallella JR; Saporito M; Lund S; Leist M; Hasseldam H; McGann N; Smith CS; Bozyczko-Coyne D; Flood DG
Eur J Pharmacol; 2005 May; 515(1-3):179-87. PubMed ID: 15904918
[TBL] [Abstract][Full Text] [Related]
11. Similar potency of catechin and its enantiomers in alleviating 1-methyl-4-phenylpyridinium ion cytotoxicity in SH-SY5Y cells.
Ruan HL; Yang Y; Zhu XN; Wang XL; Chen RZ
J Pharm Pharmacol; 2011 Sep; 63(9):1169-74. PubMed ID: 21827489
[TBL] [Abstract][Full Text] [Related]
12. Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl.
Andoh T; Chock PB; Murphy DL; Chiueh CC
Mol Pharmacol; 2005 Nov; 68(5):1408-14. PubMed ID: 16099847
[TBL] [Abstract][Full Text] [Related]
13. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.
Sanz E; Quintana A; Battaglia V; Toninello A; Hidalgo J; Ambrosio S; Valoti M; Marco JL; Tipton KF; Unzeta M
J Neurochem; 2008 Jun; 105(6):2404-17. PubMed ID: 18331475
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effect of polypeptide from Chlamys farreri on neuroblastoma (SH-SY5Y) cells following HO exposure involves scavenging ROS and inhibition JNK phosphorylation.
Ye J; Han Y; Wang C; Yu W
J Neurochem; 2009 Oct; 111(2):441-51. PubMed ID: 19682211
[TBL] [Abstract][Full Text] [Related]
16. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
[TBL] [Abstract][Full Text] [Related]
17. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.
Maroney AC; Finn JP; Connors TJ; Durkin JT; Angeles T; Gessner G; Xu Z; Meyer SL; Savage MJ; Greene LA; Scott RW; Vaught JL
J Biol Chem; 2001 Jul; 276(27):25302-8. PubMed ID: 11325962
[TBL] [Abstract][Full Text] [Related]
18. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
20. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase.
Crocker SJ; Hayley SP; Smith PD; Mount MP; Lamba WR; Callaghan SM; Slack RS; Park DS
J Neurochem; 2006 Jan; 96(2):489-99. PubMed ID: 16336220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
